Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Aminah Jatoi, M.D.

Back to Research Profile

  1. Jacobs NL, Que FG, Miller RC, Vege SS, Farnell MB, Jatoi A. Cumulative Morbidity and Late Mortality in Long-Term Survivors of Exocrine Pancreas Cancer. J Gastrointest Cancer 2009 Aug 29. [Epub ahead of print]
    View PubMed
  2. Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer 2009 Aug 07. [Epub ahead of print]
    View PubMed
  3. Chen J, Jiang R, Garces YI, Jatoi A, Stoddard SM, Sun Z, Marks RS, Liu Y, Yang P. Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients. Lung Cancer 2009 Jun 02. [Epub ahead of print]
    View PubMed
  4. Jatoi A. Cancer chemotherapy: with or without food? Support Care Cancer 2009 Jun 01. [Epub ahead of print]
    View PubMed
  5. Huang J, Jatoi A. Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression: a case series on end-of-life care. J Palliat Med 2009 Mar; 12(3):219-22.
    View PubMed
  6. Anderson R, Jatoi A, Robert C, Wood LS, Keating KN, Lacouture ME. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs). Oncologist 2009 Mar; 14(3):291-302. Epub 2009 Mar 10.
    View PubMed
  7. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR, Deschamps C. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg 2009 Feb; 87(2):392-8; discussion 398-9.
    View PubMed
  8. Tan TS, Walia T, Galanis E, Goetz MP, Rubin J, Jatoi A. If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees. J Cancer Educ 2009; 24(3):200-3.
    View PubMed
  9. Anderson R, Jatoi A, Robert C, Wood LS, Keating KN, Lacouture ME. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs). Oncologist 2009; 14(3):291-302.
    View PubMed
  10. Heun JM, Jatoi A. Osseous metastases: drugs that enhance bone intregity and prevent adverse skeletal events. Expert Opin Pharmacother 2009; 10(5):723-6.
    View PubMed
  11. Jatoi A, Green EM, Rowland KM Jr, Sargent DJ, Alberts SR. Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147. Oncology 2009; 77(2):120-3. Epub 2009 Jul 22.
    View PubMed
  12. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: a new definition. Clin Nutr 2008 Dec; 27(6):793-9. Epub 2008 Aug 21.
    View PubMed
  13. Jatoi A, Nguyen PL. Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials. Expert Opin Investig Drugs 2008 Dec; 17(12):1787-90.
    View PubMed
  14. Walia T, Quevedo JF, Hobday TJ, Croghan G, Jatoi A. Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag 2008 Dec; 4(6):1363-6.
    View PubMed
  15. Jatoi A, Nguyen PL. Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy. Oncologist 2008 Nov; 13(11):1201-4. Epub 2008 Nov 06.
    View PubMed
  16. Jatoi A, Rowland K, Sloan JA, Gross HM, Fishkin PA, Kahanic SP, Novotny PJ, Schaefer PL, Johnson DB, Tschetter LK, Loprinzi CL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer 2008 Aug 15; 113(4):847-53.
    View PubMed
  17. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol 2008 Jul 20; 26(21):3511-6.
    View PubMed
  18. Solomon BM, Jatoi A. Rash from EGFR inhibitors: opportunities and challenges for palliation. Curr Oncol Rep 2008 Jul; 10(4):304-8.
    View PubMed
  19. Clark MM, Novotny PJ, Patten CA, Rausch SM, Garces YI, Jatoi A, Sloan JA, Yang P. Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer 2008 Jul; 61(1):117-22. Epub 2008 Feb 19.
    View PubMed
  20. Mateen FJ, Jatoi A, Lineberry TW, Aranguren D, Creagan ET, Croghan GA, Jett JR, Marks RS, Molina JR, Richardson RL. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology 2008 Jul; 17(7):721-5.
    View PubMed
  21. Galanis E, Carlson SK, Foster NR, Lowe V, Quevedo F, McWilliams RR, Grothey A, Jatoi A, Alberts SR, Rubin J. Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol Ther 2008 May; 16(5):979-84. Epub 2008 Mar 18.
    View PubMed
  22. Jatoi A, Dakhil SR, Foster NR, Ma C, Rowland KM Jr, Moore DF Jr, Jaslowski AJ, Thomas SP, Hauge MD, Flynn PJ, Stella PJ, Alberts SR. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). J Thorac Oncol 2008 May; 3(5):516-20.
    View PubMed
  23. McKean H, Looker S, Hartmann LC, Hayman SR, Kaur JS, McWilliams RR, Peethambaram PP, Stahl JF, Jatoi A. Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions. J Nutr Educ Behav 2008 May-Jun; 40(3):144-8.
    View PubMed
  24. Halfdanarson TR, Thordardottir E, West CP, Jatoi A. Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol 2008 May-Jun; 6(5):234-7.
    View PubMed
  25. Jatoi A. Weight loss in patients with advanced cancer: effects, causes, and potential management. Curr Opin Support Palliat Care 2008 Mar; 2(1):45-8.
    View PubMed
  26. Kovtun IV, Engh J, Jatoi A. A survey of patient advocates within the National Cancer Institute's Prostate Cancer SPORE Program: who are they? what motivates them? what might they tell us? J Cancer Educ 2008; 23(4):222-5.
    View PubMed
  27. Halfdanarson T, Thordardottir E, West CP, Jatoi A. Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol 2008; 6(5):234-7.
    View PubMed
  28. Katipamula R, Jatoi A, Foster N, Nichols F, Rubin J, Callister M, Gunderson L, Alberts. Pemetrexed, carboplatin, and concomitnat radiation followed by surgery for locally advanced esophageal cancer: results of a planned interim toxicity analysis of the North Central Cancer Treatment Group Study N044E. Clin Med Oncol 2008; 2:223-5.
    View PubMed
  29. Singh PP, Jatoi A. Do gender-based disparities in authorship also exist in cancer palliative care? A 15-year survey of the cancer palliative care literature. J Cancer Educ 2008; 23(3):192-4.
    View PubMed
  30. Jatoi A, Miller RC. Should be recommend surgery to patients with limited small cell carcinoma of the esophagus? J Thorac Oncol 2008; 3(12):1373-6.
    View PubMed
  31. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: a new definition. Clin Nutr 2008; 27(6):793-9.
    View PubMed
  32. Tan TS, Jatoi A. An update on advance directives in the medical record: findings from 1186 consecutive patients with unresectable exocrine pancreas cancer. J Gastrointest Cancer 2008; 39(1-4):100-3. Epub 2009 Jan 06.
    View PubMed
  33. Singh PP, Jatoi A. Do gender-based disparities in authorship also exist in cancer palliative care? A 15-year survey of the cancer palliative care literature. J Cancer Educ 2008; 23(3):192-4.
    View PubMed
  34. Tan TS, Walia T, Galanis E, Goetz MP, Rubin J, Jatoi A. If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees. J Cancer Edu 2008.
    View PubMed
  35. Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, Sloan J, Yang P. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort. Oncologist 2007 Dec; 12(12):1456-63.
    View PubMed
  36. Jatoi A, Martenson JA, Foster NR, McLeod HL, Lair BS, Nichols F, Tschetter LK, Moore DF Jr, Fitch TR, Alberts SR, North Central Cancer Treatment Group (N0044). Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Am J Clin Oncol 2007 Oct; 30(5):507-13.
    View PubMed
  37. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer 2007 Sep 15; 110(6):1396-403.
    View PubMed
  38. Alsawaf MA, Jatoi A. Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online? J Cancer Educ 2007 Fall; 22(3):174-6.
    View PubMed
  39. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer 2007 Jul 15; 110(2):363-8.
    View PubMed
  40. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, for the North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer 2007 Jul 15; 110(2):363-8.
    View PubMed
  41. Behl D, Jatoi A. Pharmacological options for advanced cancer patients with loss of appetite and weight. Expert Opin Pharmacother 2007 Jun; 8(8):1085-90.
    View PubMed
  42. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc 2007 Jun; 82(6):751-70.
    View PubMed
  43. Ma C, Jatoi A. Wine for appetite loss: "how do you know?". J Clin Oncol 2007 Apr 1; 25(10):1285-7.
    View PubMed
  44. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 2007 Apr 1; 67(5):1318-22.
    View PubMed
  45. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol 2007 Mar; 5(3):119-125.
  46. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol 2007 Mar; 5(3):119-25, 128.
    View PubMed
  47. Ma C, Mandrekar SJ, Alberts SR, Croghan GA, Jatoi A, Reid JM, Hanson LJ, Bruzek L, Tan AD, Pitot HC, Erlichman C, Wright JJ, Adjei AA. A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies. Cancer Chemother Pharmacol 2007 Feb; 59(2):207-15 Epub 2006 Jun 9.
    View PubMed
  48. Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, Tan W, North Central Cancer Treatment Group. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 2007 Feb; 69(2):289-94.
    View PubMed
  49. Halfdanarson TR, Jatoi A. Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial. Support Cancer Ther 2007 Jan 1; 4(2):119-22.
    View PubMed
  50. Jatoi A, Aranguren D. A critical look at the role of chemotherapy in older patients with non-small cell lung cancer. J Thorac Oncol 2007 Jan; 2(1):83-90.
    View PubMed
  51. Jatoi A, Nguyen PL, Foster N, Sun D, Stella PJ, Campbell M, Tschetter LK, Dakhil SR, Mailliard JA, Nikcevich DA. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol 2007 Jan; 5(1):41-6.
    View PubMed
  52. McKean H, Miller RC, Jatoi A. Non-traumatic vertebral fractures in patients with locally advanced esophageal cancer: a previously unreported, unrecognized problem. Dis Esophagus 2007; 20(2):102-6.
    View PubMed
  53. Halfdanarson T, Jatoi A. Chocolate as a cough suppressant: the rationale and justification for an upcoming clinical trial. Support Cancer Ther 2007; 4(2):119-22.
    View PubMed
  54. Jatoi A. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach. J Support Oncol 2006 Nov-Dec; 4(10):499-502.
    View PubMed
  55. Jatoi A, Burch P, Hillman D, Vanyo J, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn P, Young C, Tan W. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a phase II study from the North Central Cancer Treatment Group. J Urol 2006 Oct 19; 69(2):289-294.
  56. Mateen F, Jatoi A. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr 2006 Oct; 25(5):711-5. Epub 2006 Jul 25.
    View PubMed
  57. Jatoi A, Jacobs JA, Zimmermann E, Johnson ME, Nguyen PL, Hartmann LC. Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota. Minn Med 2006 Oct; 89(10):42-4.
    View PubMed
  58. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006 Fall; 4(4):143-52.
    View PubMed
  59. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006 Fall; 4(4):143-52.
    View PubMed
  60. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006 Fall; 4(4):143-52.
    View PubMed
  61. Patiyil S, Chan SN, Jatoi A. New agents, new rashes: an update on skin complications from cancer chemotherapy. Curr Oncol Rep 2006 Jul; 8(4):269-74.
    View PubMed
  62. Chan SN, Okuno SH, Jatoi A. Causes and outcomes of spontaneous pneumothoraces in solid tumor cancer patients: an update for the medical oncologist. J Thorac Oncol 2006 May; 1(4):335-8.
    View PubMed
  63. Giordano KF, Jatoi A, Stella PJ, Foster N, Tschetter LK, Alberts SR, Dakhil SR, Mailliard JA, Flynn PJ, Nikcevich DA. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Ann Oncol 2006 Apr; 17(4):652-6.
    View PubMed
  64. Giordano KF, Jatoi A, Stella PJ, Foster N, Tschetter LK, Alberts SR, Dakhil SR, Mailliard JA, Flynn PJ, Nikcevich DA, North Central Cancer Treatment Group. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Ann Oncol 2006 Apr; 17(4):652-6. Epub 2006 Feb 23.
    View PubMed
  65. Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Ann Oncol 2006 Jan; 17(1):29-34.
    View PubMed
  66. Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM Jr, North Central Cancer Treatment Group. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Ann Oncol 2006 Jan; 17(1):29-34. Epub 2005 Nov 22.
    View PubMed
  67. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol 2006; 4(4):143-52.
    View PubMed
  68. McKian KP, Miller RC, Cassivi SD, Jatoi A. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy. Dis Esophagus 2006; 19(6):448-53.
    View PubMed
  69. Jatoi A, Foster N, Wieland B, Murphy B, Nikcevich D, LaPlant B, Palcic MM, Baracos V. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer. Dis Esophagus 2006; 19(4):241-7.
    View PubMed
  70. Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005 Dec 20; 23(36):9113-9.
  71. Jatoi A, Giordano KF, Nguyen PL, Sloan J, Hartmann LC. Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group. Support Cancer Ther 2005 Oct 1; 3(1):59-62.
    View PubMed
  72. Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL. Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution. Lung Cancer 2005 Aug; 49(2):209-15.
    View PubMed
  73. Jatoi A. Omega-3 fatty acid supplements for cancer-associated weight loss. Nutr Clin Pract 2005 Aug; 20(4):394-9.
    View PubMed
  74. Jatoi A, Williams B, Nichols F, Marks R, Aubry MC, Wampfler J, Finke EE, Yang P. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer 2005 Jul; 49(1):77-84.
    View PubMed
  75. Giordano KF, Jatoi A. The cancer anorexia/weight loss syndrome: therapeutic challenges. Curr Oncol Rep 2005 Jul; 7(4):271-6.
    View PubMed
  76. Jatoi A. Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome? Crit Rev Oncol Hematol 2005 Jul; 55(1):37-43.
    View PubMed
  77. Jatoi A, Alberts SR, Foster N, Morton R, Burch P, Block M, Nguyen PL, Kugler J. Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group. Support Care Cancer 2005 Jun; 13(6):381-6.
    View PubMed
  78. Joque L, Jatoi A. Total parenteral nutrition in cancer patients: why and when? Nutrition in Clinical Care 2005 Apr-Jun; 8(2):89-92.
    View PubMed
  79. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's is 20-year experience. Cancer 2005 Feb 15; 103(4):863-8.
    View PubMed
  80. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, Petersen RC. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer 2005 Jan; 13(1):66-9.
    View PubMed
  81. Jatoi A, Giordano KF, Nguyen PL, Sloan JA, Hartmann LC. Targeting and Palliating Ascites: An Overview of an Upcoming Clinical Trial from the North Central Cancer Treatment Group. Support Cancer Ther 2005; 3(1):59-62.
    View PubMed
  82. Jatoi A, Williams BA, Marks R, Nichols FC, Aubry MC, Wampfler J, Yang P. Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: Results from the Mayo Clinic Lung Cancer Cohort. Nutr Cancer 2005; 51(1):7-12.
    View PubMed
  83. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer 2004 Dec; 12(12):859-63.
    View PubMed
  84. Jatoi A, Martenson J, Mahoney MR, Lair BS, Brindle JS, Nichols F, Caron N, Rowland K, Tschetter L, Alberts S. Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: Preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group. International Seminars in Surgical Oncology 2004 Nov 8; 1.
    View PubMed
  85. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer 2004 Sep; 12(9):640-4.
    View PubMed
  86. Jatoi A, Sideras K, Nguyen PL. Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome. Support Cancer Ther 2004 Jul 1; 1(4):237-42.
    View PubMed
  87. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004 Jun 15; 22(12):2469-76.
    View PubMed
  88. Young CYF, Jatoi A, Ward JF, Blute ML. The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. Curr Med Chem 2004 Apr; 11(7):909-23.
    View PubMed
  89. Kanard A, Jatoi A, Castillo R, Geyer S, Schulz TK, Fitch TR, Rowland KM, Nair S, Krook JE, Kugler JW. Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity. Lung Cancer 2004 Mar; 43(3):345-53.
    View PubMed
  90. Kanard A, Frytak S, Jatoi A. Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol 2004 Mar-Apr; 2(2):127-32; discussion 133-5, 138-40.
    View PubMed
  91. de Andrade M, Ebbert JO, Wampfler JA, Miller DL, Marks RS, Croghan GA, Jatoi A, Finke EE, Sellers TA, Yang P. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer 2004 Feb; 43(2):127-34.
    View PubMed
  92. Jatoi A, Nguyen PL. Weight loss in lung cancer patients with refractory, metastatic disease: clinical implications and therapeutic strategies. Oncology Nutrition Connection 2004 Spr; 12(2):1, 3-5.
  93. Jatoi A, Podratz KC, Gill P, Hartmann LC. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol 2004; 2(4):323-34.
    View PubMed
  94. Jatoi A, Foster N, Johnson P, Klee G, Quevedo JF, Morton RF, Nair S, Kardinal CG, Mailliard JA. Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group. Dis Esophagus 2004; 17(4):292-6.
    View PubMed
  95. Jatoi A. Aggressive multimodality therapy for patients with locally advanced esophageal cancer: Is there a role for amifostine? Semin Oncol 2003 Dec; 30(6 Suppl 18):72-5.
    View PubMed
  96. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol2003 Nov-Dec; 1(4):274-8.
    View PubMed
  97. Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study. Am J Clin Oncol 2003 Oct; 26(5):441-7.
    View PubMed
  98. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003 Sep 1; 21(17):3201-6.
    View PubMed
  99. Jatoi A, Hillman S, Stella PJ, Mailliard JA, Sloan J, Vanone S, Cannon MW, Kutteh L, Kanard A, Jett JR. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer 2003 Jul; 11(7):460-4.
    View PubMed
  100. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Research & Treatment 2003 Jul; 80(1):99-104.
    View PubMed
  101. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol 2003 May 1; 21(9 Suppl):79S-81S.
    View PubMed
  102. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CYF, Flynn PJ. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003 Mar 15; 97(6):1442-6.
    View PubMed
  103. Jatoi A. Why should we care about the cancer anorexia/weight loss syndrome? Oncology (Huntington) 2003 Feb; 17(2 Suppl 2):5-6.
    View PubMed
  104. Somerfield M, Jatoi A, Nguyen PL, Kumar S, Sloan J, Loprinzi CL. Hazards of quality-of-life data for clinical decision making. J Clin Oncol 2003; 21(9 suppl):82-3.
    View PubMed
  105. Jatoi A, Loprinzi CL. The cancer anorexia/weight loss syndrome-a review of therapeutic strategies. Business Briefing:European PharmacoTherapy 2003;102-4.
  106. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group Study. J Clin Oncol 2002 Jan 15; 20(2):567-73.
    View PubMed
  107. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer 2002 Jan; 10(1):71-5.
    View PubMed
  108. Jatoi A, Thomas CR. Esophageal cancer and the esophagus: Challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatment. Semin Radiat Oncol 2002 Jan; 12(1 Suppl 1):62-7.
    View PubMed
  109. Jatoi A, Tirona MT, Cha SS, Alberts SR, Nair S, Kardinal CG, Rowland KM, Morton RE, Stella PJ, Mailliard JA, Sargent D, Goldberg RM. A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia. International Journal of Gastrointestinal Cancer 2002; 32(2-3):115-23.
  110. Jatoi A, Nguyen PL. Anorexia: Treatment options for patients with advanced cancer. Am J Cancer 2002; 1(4):269-75.
  111. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer 2001 Aug 1; 92(3):629-33.
    View PubMed
  112. Jatoi A, Daly BDT, Hughes VA, Dallal GE, Kehayias J, Roubenoff R. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg 2001 Aug; 72(2):348-351.
    View PubMed
  113. Jatoi A, Daly EDT, Kramer G, Mason JB. Folate status among patients with non-small cell lung cancer: a case-control study. J Surg Oncol 2001 Aug; 77(4):247-252.
    View PubMed
  114. Jatoi A, Cleary MP, Tee CM, Nguyen PL. Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice. Ann Nutr Metab 2001 May-Jun; 45(3):116-120.
    View PubMed
  115. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care 2001 May; 4(3):179-82.
    View PubMed
  116. Jatoi A, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology (Huntington NY) 2001 Apr; 15(4):497-509.
    View PubMed
  117. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol 2000 Aug; 18(15):2930-2.
    View PubMed
  118. Clark JL, Nguyen PL, Jaszcz WB, Jatoi A, Niehans GA. Prognostic variables in male breast cancer. Am Surg 2000 May; 66(5):502-11.
    View PubMed
  119. Jatoi A, Loprinzi CL. Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am 1999 Oct; 79(5):1145-56.
    View PubMed
  120. Jatoi A, Daly BD, Hughes V, Dallal GE, Roubenoff R. The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer. Lung Cancer 1999 Feb; 23(2):153-8.
    View PubMed
  121. Jatoi A, Dallal GE, Nguyen PL. False-negative rates of tumor metastases in the histologic examination of bone marrow. Mod Pathol 1999 Jan; 12(1):29-32.
    View PubMed
  122. Jatoi A, Nguyen PL. Can pathology residents be taught to perform adequate bone marrow biopsies? Acad Med 1999; 74(4):452.
    View PubMed
  123. Jatoi A, Garcia-Moliner ML, Daly BD. Parosteal osteosarcoma from a rib. Ann Thorac Surg 1998; 65(1):265-7.
    View PubMed
  124. Camilo ME, Jatoi A, O'Brien M, Davidson K, Sokoll L, Sadowski JA, Mason JB. Bioavailability of phylloquinone from an intravenous lipid emulsion. Am J Clin Nutr 1998; 67(4):716-21.
    View PubMed
  125. Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin intake in post-operative non-small cell lung cancer patients. J Surg Oncol 1998; 68(4):231-6.
    View PubMed
  126. Jatoi A, Jaromin R, Jennings L, Nguyen PL. Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable. Clin Lab Manage Rev 1998; 12(4):256-60.
    View PubMed
  127. Jatoi A, Lennon C, O'Brien M, Sadowski J, Mason JB. Protein-calorie malnutrition does not predict subtle vitamin K pepletion in hospitalized patients. Eur J Clinl Nutr 1998; 52:934-7.
  128. Jatoi A, Hanjosten K, Ross E, Mason JB. A prospective survey for central line skin-site colonization by the pathogen malassezia furfur among hospitalized adults receiving total parenteral nutrition. JPEN 1997; 21(4):230-2.
  129. Jatoi A, Jaromin R, Gryzbek D, Nguyen PL. Surveying technologists: a novel method for establishing productivity standards in a clinical hematology laboratory. Health Manpower Management 1997; 23(45):167-9.
    View PubMed
  130. Ward JC, Gitlin JB, Garry DJ, Jatoi A, Luikart SD, Zelickson BD, Dahl MV, Skubitz KM. Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity. Br J Haematol 1992 May; 81(1):27-32.
    View PubMed
  131. Massouh M, Jatoi A, Gordon EM, Ratnoff OD. Heparin co-factor II activity in plasma during pregnancy and oral contraceptive use. J Lab Clin Med 1989; 114(6):697-9.
    View PubMed
  132. Ma C, Jatoi A. Wine for Appetite Loss: "How do you know?" J Clin Oncol 2007; 25(10):1285-7.
    View PubMed
  133. Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, Tan W. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 2007 Feb; 69(2):289-94.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.